Who
Artal Participations S.a r.l.
Director
Company insider
Files Form 4 as: Director, CAVA Group; Director and 10% owner, Lexicon Pharmaceuticals.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $541.8M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 17 Feb 2026
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | CAVA CAVA GroupRestaurants | SEC FORM 4 Sold | $270.9M3,000,000 at $90.30 | filing |
| 15 Jun 2026filed 17 Jun 2026 | CAVA CAVA GroupRestaurants | SEC FORM 4 Sold | $270.9M3,000,000 at $90.30 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —20,421,735 at $0.00 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —408,434.7 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —408,434.7 at $0.00 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —408,434.7 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —408,434.7 at $0.00 | filing |
| 30 Apr 2026filed 8 May 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —20,421,735 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $2.7M41,289.58 at $65.00 | filing |
News
Critical Survey: CAVA Group (NYSE:CAVA) versus Trip.com Group (NASDAQ:TCOM)CAVA · themarketsdaily.com · 14 Oct 2026Head-To-Head Comparison: Papa John's International (NASDAQ:PZZA) & CAVA Group (NYSE:CAVA)CAVA · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Artal Participations S.a r.l.; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.